Molecular-Targeted Therapy for Duchenne Muscular Dystrophy: Progress and Potential

By Scimè Anthony   Rudnicki Michael A.  

Molecular Diagnosis & Therapy, Vol. 12, Iss. 2, 2008-01 ,pp. : 99-108

Adis International

Access to resources Recommend Favorite

Selective PCAF inhibitor ameliorates cognitive and behavioral deficits by suppressing NF-κB-mediated neuroinflammation induced by Aβ in a model of Alzheimer's disease

By                

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 1109-1118

Spandidos Publications

Access to resources Recommend Favorite

Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein

By Waza Masahiro   Adachi Hiroaki   Katsuno Masahisa   Minamiyama Makoto   Tanaka Fumiaki   Doyu Manabu   Sobue Gen  

Journal of Molecular Medicine, Vol. 84, Iss. 8, 2006-08 ,pp. : 635-646

Springer Publishing Company

Access to resources Recommend Favorite

A Prognostic Indicator of Survival in Metastatic Colorectal Cancer Patients in the Era of Molecular-Targeted Agents: The Modified Glasgow Prognostic Score

By  

Oncology, Vol. 86, Iss. 1, 2013-12 ,pp. : 44-45

Karger

Access to resources Recommend Favorite

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 154-166

Karger

Access to resources Recommend Favorite